FDA issued a Warning Letter to Medtronic, Inc. on 7/17/2012 as a result of this inspection.
FDA investigators audited the Medtronic Neuromodulation - Minneapolis, MN, United States facility and issued 6 inspectional observations (via FDA 483) on 09 May 2012.
Add To Cart
- Category: Medical Devices & Rad Health / Human Drugs
- Number of Observations: 6
- Inspection end: 09 May 2012
- Location: Minneapolis, United States
- FEI: 2182207